SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

A protein can speed up recovery after radiation and chemo Shows promise in animal experiments

Patient engagement solutions market expected to soar Will hit $13.7 billion by 2019

Big data platform designed for new value-based model Helps physicians improve outcomes while reducing costs

Hospitals saving billions on charity care ACA may save expansion state hospitals up to $4.2 billion in 2014

FDA approves GE's new PET/CT Higher sensitivity and field-of-view

Consensys joins forces with Oncology Services International A strategic alliance among ISOs

Checking in with the first installed MEVION S250 Assessing nine months of single room proton therapy

MEDICA 2014: IT Matters at MEDICA Health IT takes center stage at a number of presentations

Scripps' pencil-beam proton center had "exceptional results" Treated more tumor sites in seven months than others have

Proton therapy is promising for breast cancer Reduces risk of heart attack

Deal valued at $5.7 million.

Accuray to buy radiation therapy software company for $5.7 million

by Brendon Nafziger , DOTmed News Associate Editor
Accuray Inc. said Monday that it would buy Morphormics Inc., a company that designs software for planning prostate radiation treatments, for approximately $5.7 million.

Accuray said it has been licensing Morphormics' technology since 2008, shortly before the product was first released commercially in 2009 as part of an Accuray treatment planning system.

Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250 DOTmed Certified



Morphormics' autocontouring software uses mathematical models to create individual 3-D atlases of patients' organs based on CT and other medical images. Its first product, MxStruct/Pelvis, can identify and mark the boundaries of the prostate so radiation oncologists can better target the organ while sparing surrounding healthy tissue.

The company was spun off from University of North Carolina at Chapel Hill in 2001 by professors Edward Chaney, Stephen Pizer and Sarang Joshi.

With the deal, Accuray said it would extend autocontouring abilities for its CyberKnife and TomoTherapy systems. Sunnyvale, Calif.-based Accuray acquired TomoTherapy last year.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED